[Increased creatine phosphokinase (CPK) level and muscle symptoms during beta-blocker therapy].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D002354:Carteolol / Q000009:adverse effects; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects*; D010869:Pindolol / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D002354:Carteolol; D010869:Pindolol; D003402:Creatine Kinase